AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Gliris-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Bioiris Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliris-M 1 Tablet PR

Diabex Duo, a single-dose tablet, is classified as an antidiabetic agent. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect of Diabex Duo. Familiarize yourself with hypoglycemia symptoms like sweating, dizziness, headache, and tremors, and learn appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. Diabex Duo is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or lactating women requires medical consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Gliris-M 1 Tablet PR

No information provided. A rephrased text cannot be generated without the original text.

Uses of Gliris-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Gliris-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer one Gliris-M PR tablet with a meal.

Common Side effects of Gliris-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliris-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Gliris-M 1 Tablet PR with a meal.

How Gliris-M 1 Tablet PR works:

Gliris-M 1 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliris-M 1 Tablet PR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliris-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Postpartum administration of Gliris-M 1 Tablet PR is contraindicated due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Gliris-M 1 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult your physician for guidance. Gliris-M 1 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliris-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; however, its administration is contraindicated in those with severe liver disease.

What if you forget to take Gliris-M 1 Tablet PR :

Should you forget a Gliris-M 1 Tablet PR dose, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gliris-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Gliris-M 1 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliris-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Gliris-M 1 Tablet PR and seek immediate medical attention.
Gliris-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Gliris-M 1 Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Gliris-M 1 Tablet PR use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake at least annually is recommended by some researchers.
Gliris-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliris-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Gliris-M 1 Tablet PR
78
MRP 90
13% off